ADARx Pharmaceuticals, Inc. is seeking a public listing via IPO on Nasdaq, having filed the S-1 registration statement with the SEC and appointing Morgan Stanley as joint bookrunner.

The entities involved

• Morgan Stanley →

  U.S. investment bank

  • Financial firms including Morgan Stanley, Truist Financial, Jefferies Financial Group, and CIBC issued rating and price objective updates for Clearway Energy.Mon 17:33
  • Goldman Sachs, Morgan Stanley, JPMorgan Chase, and Bank of America are competing in the global investment banking sector.Mon 17:24
• SEC →

  Slovak company

  • DHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Mon 17:57
  • The Fidelis Partnership is incorporating in Bermuda and filing for an initial public offering on the NYSE, with principal offices in London and a main office in Dublin.Mon 17:12

Related events

• Amaero Inc. filed an S-1 registration statement with the SEC to seek an Initial Public Offering listing on Nasdaq, with Baird running the deal.Aug 28
• Electra Therapeutics is seeking an IPO listing on Nasdaq, retaining TD Cowen as joint bookrunner and filing S-1.Aug 28
• Allarity Acquisition Corp. filed its S-1 Registration Statement with the SEC and applied to list its units on Nasdaq for its IPO.Sep 11
• Iambic Therapeutics is seeking a public offering via S-1 filing with the SEC, aiming for a listing on the exchange, with Citigroup involved as part of the leading underwriting syndicate.Sep 22
• Aardvark Therapeutics filed IPO documents with the SEC.Sep 23